Back to Journals » Open Access Rheumatology: Research and Reviews » Volume 3

Review

Combination therapy versus celecoxib, a single selective COX-2 agent, to reduce gastrointestinal toxicity in arthritic patients: patient and cost-effectiveness considerations

       
Total article views   HTML views PDF downloads Totals
13,660 Dovepress* 11,210+ 4,576 15,786
PubMed Central* 2,450 133 2,583
Totals 13,660 4,709 18,369
*Since 4 August 2011
+Since July 2016

View citations on PubMed Central and Google Scholar